Sugi Predict

Sugi Predict / Compounds / SCHEMBL564528

SCHEMBL564528

SCHEMBL564528

CC(C)(C)CC[C@@H](C(=O)O)N1CC(COCc2ccccc2)CC1=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ AGTR2 P50052 1/20 0.41
▸ FKBP1A P62942 1/20 0.37
▸ CTSL P07711 1/20 0.37
▸ CTSB P07858 1/20 0.37
▸ CTSK P43235 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ BUB1 O43683 1/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ PTPN1 P18031 1/20 0.36
▸ YAP1 P46937 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3064134 0.88 AGTR2 (0.43) AGTR2FKBP1ACTSLCTSBCTSK
SCHEMBL564527 0.83 AGTR2 (0.40) AGTR2CTSLCTSBCTSKPPARA
SCHEMBL12206451 0.82 AGTR2 (0.43) AGTR2FKBP1ACTSLCTSBCTSK
SCHEMBL562781 0.82 AGTR2 (0.43) AGTR2FKBP1ACTSLCTSBCTSK
SCHEMBL10239722 0.79 AGTR2 (0.40) AGTR2FKBP1ACTSLCTSBCTSK
SCHEMBL563201 0.77 BRD4 (0.45) MAPTKMT2A
SCHEMBL28778765 0.77 KMT2A (0.52) AGTR2CTSLCTSBCTSKBUB1
SCHEMBL28778762 0.77 KMT2A (0.52) AGTR2CTSLCTSBCTSKBUB1
SCHEMBL28778767 0.77 KMT2A (0.52) AGTR2CTSLCTSBCTSKBUB1
SCHEMBL564529 0.72 AGTR2 (0.41) AGTR2FKBP1ACTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492416-B2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses UCB PHARMA, S.A. (BE) 2013-07-23 — — US disclosed
US-20120035239-A1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB Biopharma SRL (BE) 2012-02-09 — — US disclosed
US-8034958-B2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses UOB Pharma, S.A. (BE) 2011-10-11 — — US disclosed
US-20050171187-A1 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses DIFFERDING EDMOND (BE) 2005-08-04 — — US disclosed
US-6911461-B2 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse UCB, S.A. (BE) 2005-06-28 — — US disclosed
US-20040116507-A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses UCB Biopharma SRL (BE) 2004-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171187-A1 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses CYP1B1, OGDH, CYP1A2 AGTR2 2408/4885FKBP1A 34/4885CTSL 2002/4885
US-20120035239-A1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES CYP1B1, OGDH, CYP1A2 AGTR2 2408/4885FKBP1A 34/4885CTSL 2002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.